Correlation Between SAB Biotherapeutics and Artelo Biosciences
Can any of the company-specific risk be diversified away by investing in both SAB Biotherapeutics and Artelo Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SAB Biotherapeutics and Artelo Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SAB Biotherapeutics and Artelo Biosciences, you can compare the effects of market volatilities on SAB Biotherapeutics and Artelo Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SAB Biotherapeutics with a short position of Artelo Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of SAB Biotherapeutics and Artelo Biosciences.
Diversification Opportunities for SAB Biotherapeutics and Artelo Biosciences
-0.4 | Correlation Coefficient |
Very good diversification
The 3 months correlation between SAB and Artelo is -0.4. Overlapping area represents the amount of risk that can be diversified away by holding SAB Biotherapeutics and Artelo Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Artelo Biosciences and SAB Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SAB Biotherapeutics are associated (or correlated) with Artelo Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Artelo Biosciences has no effect on the direction of SAB Biotherapeutics i.e., SAB Biotherapeutics and Artelo Biosciences go up and down completely randomly.
Pair Corralation between SAB Biotherapeutics and Artelo Biosciences
Given the investment horizon of 90 days SAB Biotherapeutics is expected to under-perform the Artelo Biosciences. But the stock apears to be less risky and, when comparing its historical volatility, SAB Biotherapeutics is 11.12 times less risky than Artelo Biosciences. The stock trades about 0.0 of its potential returns per unit of risk. The Artelo Biosciences is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest 10.00 in Artelo Biosciences on August 25, 2024 and sell it today you would lose (9.44) from holding Artelo Biosciences or give up 94.4% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 40.64% |
| Values | Daily Returns |
SAB Biotherapeutics vs. Artelo Biosciences
Performance |
| Timeline |
| SAB Biotherapeutics |
| Artelo Biosciences |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
SAB Biotherapeutics and Artelo Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with SAB Biotherapeutics and Artelo Biosciences
The main advantage of trading using opposite SAB Biotherapeutics and Artelo Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SAB Biotherapeutics position performs unexpectedly, Artelo Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Artelo Biosciences will offset losses from the drop in Artelo Biosciences' long position.| SAB Biotherapeutics vs. Processa Pharmaceuticals | SAB Biotherapeutics vs. Third Harmonic Bio | SAB Biotherapeutics vs. Cingulate Warrants | SAB Biotherapeutics vs. Anebulo Pharmaceuticals |
| Artelo Biosciences vs. Eyenovia | Artelo Biosciences vs. Arrowhead Pharmaceuticals | Artelo Biosciences vs. Krystal Biotech | Artelo Biosciences vs. BioNTech SE |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |